Head-to-head comparison
Alloy vs GOAL.MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy.
$169/mo sema · $199/mo tirz · Verified July 2026
Marked down on: Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
Desk Score
GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing
$179/mo sema · From $249/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: No named compounding pharmacy partner
GOAL.MD takes this head-to-head with the higher Desk Score, 80/100 (B−) against 60/100 (C) for Alloy. Alloy still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Alloy
60/100
C
GOAL.MD
80/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Alloy | GOAL.MD |
|---|---|---|
| Semaglutide | $169/mo$169/mo (compounded) | $179/mo$179/mo |
| Tirzepatide | $199/mo$199/mo (compounded) | From $249/molowest dose rung$249/mo (starting dose, compounded) |
| Coverage | Not listed on Alloy's site (checked July 2026) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Menopause Society-certified care with the broadest GLP-1 formulary. | Manual-renewal billing with dose-tiered brand-name pricing transparency. |
| Desk Score | 60/100C | 80/100B− |
The verdict
Desk pick — GOAL.MDGOAL.MD takes this head-to-head with the higher Desk Score, 80/100 (B−) against 60/100 (C) for Alloy. Alloy still holds its ground where its strengths line up with yours.
Choose Alloy if…
Menopause Society-certified care with the broadest GLP-1 formulary.
$169/mo sema · $199/mo tirz
Choose GOAL.MD if…
Manual-renewal billing with dose-tiered brand-name pricing transparency.
$179/mo sema · From $249/mo (lowest dose rung) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Alloy · GOAL.MD.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Alloy vs CoreAge Rx
- CoreAge Rx vs GOAL.MD
- Alloy vs Sesame Care
- GOAL.MD vs Sesame Care
- Alloy vs Shed
- GOAL.MD vs Shed
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.